GILD Insider Transactions — Page 23
2,867 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 2,201–2,300; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| DENNY JAMES M | Director | 2007-03-06 | Sale | 500.0 | $70.66 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 7,400.0 | $70.65 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 900.0 | $70.64 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 500.0 | $70.63 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 400.0 | $70.62 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 200.0 | $70.61 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 1,820.0 | $70.6 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 600.0 | $70.59 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 2,115.0 | $70.58 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 2,900.0 | $70.57 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 1,200.0 | $70.55 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 200.0 | $70.54 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 600.0 | $70.53 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 1,200.0 | $70.52 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 1,220.0 | $70.51 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 35.0 | $70.5 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 1,400.0 | $70.49 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 435.0 | $70.48 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 100.0 | $70.47 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 100.0 | $70.46 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 1,730.0 | $70.45 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 84.0 | $70.43 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 400.0 | $70.42 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 15.0 | $70.4 |
| DENNY JAMES M | Director | 2007-03-06 | Sale | 101.0 | $70.35 |
| Alton Gregg H | SVP, General Counsel | 2007-03-01 | Sale | 1,200.0 | $69.4 |
| Alton Gregg H | SVP, General Counsel | 2007-03-01 | Sale | 500.0 | $69.75 |
| Alton Gregg H | SVP, General Counsel | 2007-03-01 | Sale | 1,000.0 | $70.25 |
| Alton Gregg H | SVP, General Counsel | 2007-03-01 | Sale | 550.0 | $70.65 |
| Alton Gregg H | SVP, General Counsel | 2007-03-01 | Sale | 1,500.0 | $71.0 |
| Meyers James R | SVP Comm Ops North America | 2007-02-28 | Sale | 6,000.0 | $71.35 |
| TOOLE JOHN J | SVP, Clinical Research | 2007-02-23 | Sale | 100.0 | $73.29 |
| TOOLE JOHN J | SVP, Clinical Research | 2007-02-23 | Sale | 100.0 | $73.32 |
| TOOLE JOHN J | SVP, Clinical Research | 2007-02-23 | Sale | 6,900.0 | $73.23 |
| TOOLE JOHN J | SVP, Clinical Research | 2007-02-23 | Sale | 1,000.0 | $73.28 |
| TOOLE JOHN J | SVP, Clinical Research | 2007-02-23 | Sale | 10,000.0 | $73.3 |
| TOOLE JOHN J | SVP, Clinical Research | 2007-02-23 | Sale | 100.0 | $73.24 |
| TOOLE JOHN J | SVP, Clinical Research | 2007-02-23 | Sale | 1,200.0 | $73.27 |
| TOOLE JOHN J | SVP, Clinical Research | 2007-02-23 | Sale | 400.0 | $73.26 |
| TOOLE JOHN J | SVP, Clinical Research | 2007-02-23 | Sale | 200.0 | $73.25 |
| MILLIGAN JOHN F | EVP, Chief Financial Officer | 2007-02-22 | Sale | 700.0 | $73.67 |
| MILLIGAN JOHN F | EVP, Chief Financial Officer | 2007-02-22 | Sale | 100.0 | $73.66 |
| MILLIGAN JOHN F | EVP, Chief Financial Officer | 2007-02-22 | Sale | 4,000.0 | $73.65 |
| MILLIGAN JOHN F | EVP, Chief Financial Officer | 2007-02-22 | Sale | 1,400.0 | $73.64 |
| MILLIGAN JOHN F | EVP, Chief Financial Officer | 2007-02-22 | Sale | 1,100.0 | $73.63 |
| MILLIGAN JOHN F | EVP, Chief Financial Officer | 2007-02-22 | Sale | 400.0 | $73.61 |
| MILLIGAN JOHN F | EVP, Chief Financial Officer | 2007-02-22 | Sale | 2,600.0 | $73.6 |
| MILLIGAN JOHN F | EVP, Chief Financial Officer | 2007-02-22 | Sale | 9,700.0 | $73.59 |
| YANG TAIYIN | SVP, Pharm Dev & Mfg | 2007-02-21 | Sale | 2,200.0 | $73.79 |
| YANG TAIYIN | SVP, Pharm Dev & Mfg | 2007-02-21 | Sale | 200.0 | $73.73 |
| YANG TAIYIN | SVP, Pharm Dev & Mfg | 2007-02-21 | Sale | 2,300.0 | $73.7 |
| YANG TAIYIN | SVP, Pharm Dev & Mfg | 2007-02-21 | Sale | 400.0 | $73.78 |
| YANG TAIYIN | SVP, Pharm Dev & Mfg | 2007-02-21 | Sale | 300.0 | $73.74 |
| YANG TAIYIN | SVP, Pharm Dev & Mfg | 2007-02-21 | Sale | 14,600.0 | $73.71 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 2,800.0 | $72.33 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 100.0 | $72.36 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 2,400.0 | $72.28 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 5,591.0 | $72.34 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 1,668.0 | $72.32 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 1,580.0 | $72.37 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 1,000.0 | $72.26 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 234.0 | $72.27 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 500.0 | $72.31 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 1,100.0 | $72.29 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 400.0 | $72.3 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 731.0 | $72.23 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 1,728.0 | $72.25 |
| YOUNG KEVIN | EVP, Commercial Operations | 2007-02-20 | Sale | 10,168.0 | $72.24 |
| LEE WILLIAM A | SVP, Research | 2007-02-16 | Sale | 631.0 | $72.5 |
| LEE WILLIAM A | SVP, Research | 2007-02-16 | Sale | 1,100.0 | $72.0 |
| LEE WILLIAM A | SVP, Research | 2007-02-16 | Sale | 5,915.0 | $71.99 |
| LEE WILLIAM A | SVP, Research | 2007-02-16 | Sale | 2,700.0 | $71.98 |
| LEE WILLIAM A | SVP, Research | 2007-02-16 | Sale | 1,000.0 | $71.97 |
| LEE WILLIAM A | SVP, Research | 2007-02-16 | Sale | 2,700.0 | $71.96 |
| LEE WILLIAM A | SVP, Research | 2007-02-16 | Sale | 3,956.0 | $71.95 |
| LEE WILLIAM A | SVP, Research | 2007-02-16 | Sale | 2,550.0 | $71.94 |
| LEE WILLIAM A | SVP, Research | 2007-02-16 | Sale | 2,351.0 | $71.93 |
| LEE WILLIAM A | SVP, Research | 2007-02-16 | Sale | 1,119.0 | $71.92 |
| LEE WILLIAM A | SVP, Research | 2007-02-16 | Sale | 3,200.0 | $71.91 |
| LEE WILLIAM A | SVP, Research | 2007-02-16 | Sale | 4,778.0 | $71.9 |
| LEE WILLIAM A | SVP, Research | 2007-02-15 | Sale | 2,353.0 | $72.05 |
| LEE WILLIAM A | SVP, Research | 2007-02-15 | Sale | 2,500.0 | $72.02 |
| LEE WILLIAM A | SVP, Research | 2007-02-15 | Sale | 200.0 | $72.03 |
| LEE WILLIAM A | SVP, Research | 2007-02-15 | Sale | 500.0 | $72.06 |
| LEE WILLIAM A | SVP, Research | 2007-02-15 | Sale | 2,632.0 | $72.04 |
| LEE WILLIAM A | SVP, Research | 2007-02-15 | Sale | 11,815.0 | $72.0 |
| MARTIN JOHN C | President and CEO | 2007-02-13 | Sale | 9,000.0 | $70.71 |
| MARTIN JOHN C | President and CEO | 2007-02-13 | Sale | 6,000.0 | $70.68 |
| MARTIN JOHN C | President and CEO | 2007-02-13 | Sale | 6,000.0 | $70.79 |
| MARTIN JOHN C | President and CEO | 2007-02-13 | Sale | 4,000.0 | $70.95 |
| MARTIN JOHN C | President and CEO | 2007-02-13 | Sale | 6,000.0 | $71.04 |
| MARTIN JOHN C | President and CEO | 2007-02-13 | Sale | 4,000.0 | $71.13 |
| BISCHOFBERGER NORBERT W | EVP, Research | 2007-02-09 | Sale | 80,000.0 | $71.2 |
| BISCHOFBERGER NORBERT W | EVP, Research | 2007-02-09 | Sale | 20,000.0 | $71.25 |
| BISCHOFBERGER NORBERT W | EVP, Research | 2007-02-09 | Sale | 10,000.0 | $71.3 |
| BISCHOFBERGER NORBERT W | EVP, Research | 2007-02-09 | Sale | 23,920.0 | $71.33 |
| DAVIGNON ETIENNE | Director | 2007-02-06 | Sale | 19,000.0 | $69.95 |
| YANG TAIYIN | SVP, Pharm Dev & Mfg | 2007-02-06 | Sale | 15,900.0 | $70.22 |
| YANG TAIYIN | SVP, Pharm Dev & Mfg | 2007-02-06 | Sale | 4,100.0 | $70.24 |
| Alton Gregg H | SVP, General Counsel | 2007-02-01 | Sale | 2,400.0 | $69.9 |